{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:11:38Z","timestamp":1785769898337,"version":"3.56.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Patients with connective tissue diseases (CTDs) and pulmonary arterial hypertension (PAH) have a poor prognosis, and there is a lack of effective noninvasive prognostic tools. This study aimed to retrospectively analyze clinical data and multislice computed tomography (MSCT) chest CT parameters in CTD-PAH patients, and to develop a noninvasive prognostic model incorporating indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A total of 170 patients with CTD-PAH admitted to the First Affiliated Hospital of Nanjing Medical University between May 2010 and April 2022 were enrolled in this study. Data on chest computed tomography\u2013derived pulmonary artery diameters, esophageal dilatation, and interstitial lung disease (ILD) scores were collected. Patients were followed for 5 years to assess all-cause mortality. A nomogram incorporating MSCT parameters was developed and validated to predict the long-term prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Independent risk factors for 5-year all-cause mortality in CTD-PAH patients included main pulmonary artery diameter (MPAd) (HR: 1.109, 95% CI: 1.010-1.218,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.030*), esophageal dilatation (HR: 2.757, 95% CI: 1.220-6.230,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.015*), and ILD score (HR: 1.066, 95% CI: 1.019-1.114,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.005*). A threshold MPAd of &gt;35.70\u00a0mm was associated with a worse prognosis. The nomogram model, with a score &gt;125, predicted a significantly lower 5-year survival rate in CTD-PAH patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>MPAd, esophageal dilatation, and ILD score are independent risk factors for 5-year all-cause mortality in CTD-PAH patients. The nomogram, which integrates these MSCT parameters, provides a reliable noninvasive tool for predicting reduced 5-year survival, offering valuable prognostic insight for personalized management of CTD-PAH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rti.0000000000000855","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T07:00:07Z","timestamp":1760338807000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A Noninvasive Prognostic Model for Pulmonary Arterial Hypertension Associated With Connective Tissue Diseases Based on Multislice Chest Computed Tomography Parameters"],"prefix":"10.1097","volume":"41","author":[{"given":"Yingheng","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Rheumatology, First Affiliated Hospital of Nanjing Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nanjing Qixia Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangshu","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, First Affiliated Hospital of Nanjing Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, First Affiliated Hospital of Nanjing Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, First Affiliated Hospital of Nanjing Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaojia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, First Affiliated Hospital of Nanjing Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinsu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1]]},"reference":[{"key":"R1-20251222","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrcardio.2017.84","article-title":"Epidemiology and treatment of pulmonary arterial hypertension","volume":"14","author":"Lau","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"R2-20251222","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.10-0260","article-title":"Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype","volume":"138","author":"Chung","year":"2010","journal-title":"Chest"},{"key":"R3-20251222","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","article-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach","volume":"62","author":"Mukerjee","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R4-20251222","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1183\/09031936.00182813","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients","volume":"44","author":"Hao","year":"2014","journal-title":"Eur Respir J"},{"key":"R5-20251222","doi-asserted-by":"crossref","first-page":"103514","DOI":"10.1016\/j.autrev.2024.103514","article-title":"Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): similarities, differences and the role of autoimmunity","volume":"23","author":"Favoino","year":"2024","journal-title":"Autoimmun Rev"},{"key":"R6-20251222","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"R7-20251222","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.berh.2016.03.004","article-title":"Connective tissue disease-related pulmonary arterial hypertension","volume":"30","author":"Thakkar","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R8-20251222","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"R9-20251222","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R10-20251222","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R11-20251222","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R12-20251222","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease\u2014an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med"},{"key":"R13-20251222","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R14-20251222","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","article-title":"Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography","volume":"23","author":"Rudski","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"R15-20251222","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1378\/chest.113.5.1250","article-title":"Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Medical College of Wisconsin Lung Transplant Group","volume":"113","author":"Tan","year":"1998","journal-title":"Chest"},{"key":"R16-20251222","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1754-9485.2011.02317.x","article-title":"Oesophageal dilatation on high-resolution CT chest in systemic sclerosis: what does it signify?","volume":"55","author":"Pandey","year":"2011","journal-title":"J Med Imaging Radiat Oncol"},{"key":"R17-20251222","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1148\/radiol.11103532","article-title":"Prediction of pulmonary hypertension in patients with or without interstitial lung disease: reliability of CT findings","volume":"260","author":"Alhamad","year":"2011","journal-title":"Radiology"},{"key":"R18-20251222","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00004424-198401000-00005","article-title":"CT-determined pulmonary artery diameters in predicting pulmonary hypertension","volume":"19","author":"Kuriyama","year":"1984","journal-title":"Investig Radiol"},{"key":"R19-20251222","first-page":"117","article-title":"Computed tomography angiography in pulmonary hypertension","volume":"10","author":"Grubstein","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"R20-20251222","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1378\/chest.11-2794","article-title":"Pulmonary artery dilatation correlates with the risk of unexpected death in chronic arterial or thromboembolic pulmonary hypertension","volume":"142","author":"\u017by\u0142kowska","year":"2012","journal-title":"Chest"},{"key":"R21-20251222","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijcard.2017.01.097","article-title":"Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: a cohort study in China","volume":"236","author":"Zhao","year":"2017","journal-title":"Int J Cardiol"},{"key":"R22-20251222","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.gtc.2021.08.005","article-title":"Scleroderma and the esophagus","volume":"50","author":"Ahuja","year":"2021","journal-title":"Gastroenterol Clin North Am"},{"key":"R23-20251222","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/MCG.0000000000000989","article-title":"clinical characteristics and associated systemic diseases in patients with esophageal \u201cabsent contractility\u201d\u2014a clinical algorithm","volume":"53","author":"Laique","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"R24-20251222","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doac043","article-title":"Association of eosinophilic esophagitis with autoimmune and connective tissue disorders, and the impact on treatment response","volume":"36","author":"Xue","year":"2022","journal-title":"Dis Esophagus"},{"key":"R25-20251222","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/thoraxjnl-2014-206088","article-title":"CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE Registry","volume":"70","author":"Rajaram","year":"2015","journal-title":"Thorax"},{"key":"R26-20251222","doi-asserted-by":"crossref","first-page":"2102571","DOI":"10.1183\/13993003.02571-2021","article-title":"Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry","volume":"60","author":"Hambly","year":"2022","journal-title":"Eur Respir J"},{"key":"R27-20251222","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Thoracic Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RTI.0000000000000855","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:23:07Z","timestamp":1785766987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RTI.0000000000000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rti.0000000000000855","relation":{},"ISSN":["1536-0237"],"issn-type":[{"value":"1536-0237","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]}}}